Teva Pharmaceutical Industries Ltd. — Capital/Financing Update 2012

Mar 25, 2012

_________ false

C002��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD.7217Corporation no: 520013954Stock Exchange/Market: ���310380P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267267 , 03-9267652 Fax: 03-9267519E.mail address: elana.holzman@teva.co.ilDate of transmission: 25/03/2012              Time of broadcast: 09:40 09:39:14

Reference: 2012-02-077532

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Intention to offer EUR and CHF denominated senior notes
TevaEUNotice250312Final_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 14/03/2012
- - -
Name of the Signatory: : Desheh Eyal , Position of Signatory in the reporting corporation: Chief Financial Officer , Name of Employer Company: .
Basel Telephone: 03-9267656 , Facsimile: 03-9148678 , E-mail: tomer.amitai@teva.co.il 2